GeneOne Life Science, Inc.

KRX:011000.KS

2,560 (KRW) • At close September 13, 2024
Bedrijfsnaam GeneOne Life Science, Inc.
Symbool 011000.KS
Munteenheid KRW
Prijs 2,595
Beurswaarde 207,157,645,920
Dividendpercentage 0%
52-weken bereik 1,996 - 4,735
Industrie Biotechnology
Sector Healthcare
CEO Mr. Young-Keun Park J.D., M.B.A.
Website https://www.genels.com

An error occurred while fetching data.

Over GeneOne Life Science, Inc.

GeneOne Life Science, Inc., a biopharmaceutical company, engages in the development and contract manufacturing of gene-based-biomedicines. Its products comprise GLS-1027, which is in Phase I clinical trial for treatment of nephropathy and inflammatory diseases; GLS-1200 that is in Phase II clinical trial to treat Rhinosinusitis; GLS-1027 and GLS-1200, which is

Vergelijkbare Aandelen

Green Cross Holdings Corporation logo

Green Cross Holdings Corporation

005250.KS

15,820 KRW

JW Pharmaceutical Corporation logo

JW Pharmaceutical Corporation

001065.KS

31,000 KRW

Ildong Pharmaceutical Co., Ltd. logo

Ildong Pharmaceutical Co., Ltd.

249420.KS

13,830 KRW

Pharmicell Co., Ltd. logo

Pharmicell Co., Ltd.

005690.KS

5,300 KRW

Chong Kun Dang Pharmaceutical Corp. logo

Chong Kun Dang Pharmaceutical Corp.

185750.KS

119,100 KRW

Hanall Biopharma Co.,Ltd logo

Hanall Biopharma Co.,Ltd

009420.KS

36,000 KRW

Boryung Corporation logo

Boryung Corporation

003850.KS

10,400 KRW

Yungjin Pharm. Co., Ltd. logo

Yungjin Pharm. Co., Ltd.

003520.KS

2,330 KRW

Daewoong Co., Ltd. logo

Daewoong Co., Ltd.

003090.KS

25,500 KRW

Bukwang Pharmaceutical Co., Ltd. logo

Bukwang Pharmaceutical Co., Ltd.

003000.KS

5,020 KRW

Financiële Gegevens

Cijfers zijn in miljoenen (KRW)

Cijfers zijn in miljoenen (KRW)